| | Pycnogenol does not impact the antioxidant or vitamin C status of healthy young adultsAbstract Objective The objectives of this study were to determine if Pycnogenol (PYC), a water-processed extract made from the bark of Pinus maritima, interacts with vitamin C to increase its concentration and to increase total antioxidant capacity of serum and urine. Design The study design was a nonrandom intervention. Subjects Subjects (N=27; 15 women, 12 men) were aged 19 to 42 years. Intervention Subjects consumed a placebo twice daily with meals for the first 2 weeks (baseline) and PYC (200 mg/day) for the second 2 weeks. Main outcome measures On days 15 and 29, subjects had a fasting blood sample collected and then consumed a daily dose of placebo or PYC with a 310-calorie beverage. One hour later a second blood sample was collected. Blood samples were analyzed for vitamin C and total antioxidant capacity using the ORAC (oxygen radical absorbance capacity) assay. Twenty-four-hour urine samples were collected on days 14-15 and 28-29 and analyzed for total phenolics, FRAP (ferric reducing antioxidant potential), and ORAC. Statistical analyses Paired t tests were used to test the impact of PYC on the outcome variables. A univariate ANOVA was used to determine the influence of gender. Pearson's correlation analysis was used to explore the relationships between dietary factors and outcome measures. Results There was no apparent increase in fasting vitamin C concentration (P=.18) 2 weeks after supplementing the diet with PYC. Fasting ORAC values actually declined (P=.005). One hour after the ingestion of a daily dose of placebo or PYC, the total antioxidant capacity of serum increased by 15% to 19%, but the increase after ingesting PYC was not significantly (P=.80) more than after placebo. Antioxidant results from 24-hour urine samples were similar. Applications/conclusions The present findings fail to support the vitamin C or antioxidant claims made for PYC. PYC does not impact the antioxidant or vitamin C status of healthy young adults. J Am Diet Assoc. 2003;103:67-72. 0002-8223/03/10301-0006$35.00/0
Pycnogenol (PYC) is a dietary supplement that is heavily promoted on the internet and is commonly found in the dietary supplement section of drug and health food stores. PYC is the registered trade name for a water-processed extract made from fresh bark of the French maritime pine Pinus maritima ((1)). Although its exact chemical composition has not been completely determined, PYC seems to consist of a complex mixture of phenolic and polyphenolic substances ((2)). The main constituents are known to be polyphenolic compounds divided into the monomers (catechin, epicatechin, and taxifolin) and the condensed flavonoids (procyanidins/proanthocyanidins). Phenolic acids appear to be minor constituents (p-hydroxybenzoic acid, caffeic acid, and ferulic acid). Polyphenolic compounds are an important part of the human diet because of their antioxidant, free-radical-scavenging, and metal chelating properties [3], [4]. They are present in plant foods (vegetables, fruits, cereals, legumes, and nuts) and beverages (wine, cider, beer, tea, and cocoa) ((3)).
The functional and health claims made by distributors of PYC are numerous. Among the claims are that PYC helps the body resist inflammation; protects against blood vessel and skin damage; improves the general function of the brain; relieves the distresses of arthritis, diabetes, and stroke; acts as a powerful antioxidant; and works synergistically with vitamin C, protecting it from degradation. The two latter claims were explored in the present study. The objectives of this study were to determine whether PYC increases the concentration of vitamin C in plasma, whether it increases total antioxidant capacity of serum in the fasting state and/or in the postprandial state, and whether it increases urine total antioxidant capacity.
Methods  Subjects Twenty-seven subjects were recruited into the study from the population at California State University, Chico. Subjects were between the ages of 19 and 42 years. All subjects were in good health, were nonsmokers, and reported that they had not taken any medications or nutritional supplements in the month prior to the study. The Human Subjects in Research Committee at California State University, Chico, approved the study. Informed consent was obtained from all subjects. Study design At the time the study started, we had no information regarding how potent an antioxidant this supplement was, how long the supplement would impact antioxidant status, how bioavailable it was, how long it would take before it cleared the body, etc. Therefore, we used a nonrandomized intervention design employing deception to induce a baseline period. The study took place over 4 weeks and was divided into two 2-week periods. Subjects were asked to follow their usual diet and activity patterns for the first period of 14 days (days 1-14) and to consume placebo pills twice per day with the breakfast and the evening meals (baseline). For the second period of 14 days (days 15-28), subjects were asked to continue to follow their usual diet and activity patterns and to consume PYC twice per day with the breakfast and evening meals (100 mg at each meal or 200 mg per day-intervention; the dose used is near the high end of what is commonly recommended by distributors). Henkel Corporation (LaGrange, Ill) supplied the placebo and PYC pills. Subjects were asked to return any pills they did not consume. No pills were returned after baseline or after the intervention. Because of concerns that subjects might change their dietary intake while taking PYC, the researchers told subjects that they were conducting a study with a single-blind crossover design and that they would receive either the placebo or the PYC during the first 14 days and then be switched to the other for the second 14-day period. Twenty-four-hour urine collections were made on days 14-15 and 28-29 of the study. Only 25 urine samples were available for analysis because of improper collection. Fasting and postprandial blood collection Blood was collected at two time points in the study, day 15 after the baseline period and day 29 after the PYC phase. Subjects had a fasting (10-hour) blood draw. After the fasting blood sample was collected, subjects consumed a daily dose of placebo pills or PYC (200 mg) with a coconut beverage. The coconut beverage consisted of 19 g of coconut milk, 69 g of coffee creamer, 19 g of sugar, 13 g of Pro Mod Power (Abbott Laboratories, Columbus, OH), 13 g of Polycose powder (Abbott Laboratories), and 250 g of water. These ingredients were chosen to provide carbohydrate, fat, and protein, but not any known factors that would increase or change antioxidant status in vivo, such as phenolic compounds or nutrient antioxidants. The beverage contained 310 kcal. One hour later, a second blood sample was collected. Dietary assessment and body weight The subjects' diets were assessed using estimated food records. Subjects were asked to record all food and beverages consumed for both phases of the study (28 days). The subjects were instructed on the procedure for properly recording a food diary and on how to use household measures for estimating portion sizes. Food models, cups, measuring spoons, drinking glasses, and bowls of various sizes were used to aid instruction. In addition, subjects were shown how to read food labels so that they could record the portions of food and beverages consumed with accuracy. NUTRITIONIST V software (version 2.1, 1999, N-Squared Computing, San Bruno, Calif) was used to analyze nutrient intake (total kilocalories; percent of total calories from fat, protein, and carbohydrate; alcohol; and the nutrient antioxidants vitamin C, vitamin E, and selenium) of the food records during each of the two phases of the study. Each subject's height and weight were measured before the start and at the end of the study. Vitamin C and antioxidant analyses The plasma samples that were analyzed for vitamin C were treated with an equal volume of 8% trichloroacetic acid and centrifuged to precipitate plasma proteins. The resultant supernatants were kept frozen at −70°C prior to analysis. Serum and urine samples, collected for measurement of antioxidant capacity, were also stored at this temperature. Vitamin C (reduced ascorbic acid) analyses were performed using an ion pair reverse-phase high performance liquid chromatography method (coefficient of variance [CV] 4%) with ultraviolet detection at 266 nm ((5)). This method uses a C18 reverse-phase column (NovaPack Waters, C-18, 3.9 × 150 mm). The mobile phase contained 50 mmol/L sodium dihydrogen phosphate, 50 mmol/L sodium acetate, and 5 mmol/L hexadecyl trimethyl ammonium bromide (HTAB), pH 5.25. The HTAB binds to ascorbic acid and forms an ion pair. The serum and urine samples were analyzed for oxygen radical absorbance capacity (ORAC) using the ORAC assay (CV=10%). Serum and urine samples were treated with 0.5 N perchloric acid (1:1, volume/volume) and centrifuged, and the supernatant was analyzed. In brief, the ORAC assay is an automated assay carried out on a COBAS FARA II spectrofluorometric analyzer ((6)). In the final assay mixture, R-phycoerythrin was used as the target molecule of free radical attack with 2,2'-azobis(2-amindinopropane) dihydrochloride (AAPH) as the peroxyl radical generator. Trolox, a water-soluble analog of vitamin E, was used as the control standard, and results were expressed as μmol Trolox equivalents (TE). The PYC tablets were also analyzed by the ORAC assay. Total soluble phenolics in the urine were determined with Folin-Ciocalteu reagent by the method (CV=6%) of Slinkard and Singleton ((7)) using gallic acid as a standard. Ferric-reducing antioxidant power (FRAP) (CV=6%) was determined in urine samples by the method of Benzie and Strain ((8)), which measures the ferric-to-ferrous iron reduction in the presence of antioxidants. The 2,4,6-tripyridyl-s-triazine used in this assay was from Sigma (St. Louis, Mo). When a ferric-tripyridyltriazine (Fe3+-TPTZ) complex is reduced to the ferrous form (Fe2+), an intense blue color with absorption maximum at 593 nm develops. FRAP was standardized using Trolox. Statistical analysis The data were analyzed using SPSS (version 9.0, 1998, SPSS Inc, Chicago, Ill). The differences in the vitamin C, total phenolic, FRAP, and ORAC values; dietary intake; and changes (1-hour sample − fasting sample) in vitamin C or ORAC values between the baseline and PYC phases were analyzed using paired t tests. Because there seemed to be gender differences in some of the antioxidant measures, a univariate analysis of variance (ANOVA), using the GLM univariate procedure, was used to determine whether gender influenced the dependent variables (change between baseline and PYC phase). Pearson's correlation analysis was used to explore the relationships between dietary factors and fasting levels of vitamin C and ORAC in blood.
Results  The characteristics of the subjects are shown in Table 1.There was no change in subjects' body weights from the start of the study to the end of the study, indicating that subjects maintained energy balance throughout the study. Subjects maintained a consistent dietary pattern for both the baseline and PYC phase of the study (Table 2).There was no change in subjects' dietary intakes between the baseline and PYC phases of the study. There was no apparent increase in fasting vitamin C concentration of plasma 2 weeks after supplementing the diet with PYC (Table 3).There was a significant (P<.001) association between dietary intake of vitamin C and the concentration of vitamin C in plasma (r=.60). There was also no apparent increase in the total antioxidant capacity of serum 2 weeks after supplementing the diet with PYC (Table 3). One hour after the ingestion of a load dose of placebo or 200 mg of PYC, the antioxidant capacity of serum increased by an average of 15% to 19%. The total serum antioxidant capacity increased only 3% more than the apparent meal-induced increase in total serum antioxidant capacity 1 hour after consuming 200 mg of PYC. This increase did not reach statistical significance. Results from univariate ANOVA found that gender had no effect on the change in baseline or PYC values for any of the variables listed in Table 2. The total antioxidant capacity of the PYC used in the present study was also measured using the ORAC assay and was found to contain 3003 TE/g, giving a daily ORAC intake of 600 TE. | | |  | | Male (n=12) | Female (n=15) |  |
|---|
 | | ←mean±SD→ |  |
 | Age (y) | 27±7 | 24±5 |  |
 | Height (cm) | 178.6±3.6 | 166.6±6.6 |  |
 | Initial weight (kg) | 80.5±11.4 | 61.4±10.0 |  |
 | Final weight (kg) | 80.9±11.8 | 60.9±9.6 |  |
 | Initial body mass index | 25.3±3.5 | 22.0±3.0 |  |
 | Final body mass index | 25.7±3.6 | 21.9±2.8 |  | | | |
| | |  | | Male (n=12) | Female (n=15) |  |
|---|
 | | Baseline | Pycnogenol | Baseline | Pycnogenol |  |
|---|
 | | ←mean±SD→ | ←mean±SD→ |  |
 | Energy (kcal) | 2,748±479* | 2,603±529* | 1,738±325 | 1,797±345 |  |
 | Protein (% kcal) | 16.2±3.4 | 15.6±2.9 | 15.6±2.7 | 14.7±2.0 |  |
 | Carbohydrate (% kcal) | 52.2±5.5 | 54.6±5.4 | 57.6±8.0 | 57.9±5.7 |  |
 | Fat (% kcal) | 26.6±2.9 | 25.4±2.7 | 26.6±6.1 | 26.1±5.5 |  |
 | Alcohol (g) | 7.9±5.7 | 5.1±5.0 | 4.6±2.6 | 3.7±2.5 |  |
 | Vitamin C (mg) | 104±57 | 116±56 | 123±51 | 134±49 |  |
 | Vitamin E (ATE) | 9.4±4.7 | 11.2±6.9 | 7.5±1.9 | 8.5±3.5 |  |
 | Selenium (μg) | 145±68 | 144±99 | 117±112 | 83±16 |  | | | |
| | |  | | Male (n=12) | Female (n=15) |  |
|---|
 | | Baseline | Pycnogenol | Baseline | Pycnogenol |  |
|---|
 | | ←mean±SD→ | ←mean±SD→ |  |
 | Fasting vitamin C (μM) | 48±5 | 50±7 | 59±3 | 64±5 |  |
 | Fasting ORACa | 274±58 | 261±66* | 225±52 | 204±54* |  |
 | 1-hour ORAC | 293±49 | 282±55 | 266±46 | 248±46 |  |
 | Change in ORACa,b | 19.5±38 | 20.9±19.4 | 41.2±30 | 44.2±36.5 |  |
 | Percent change in ORACc | 8.8±14.3 | 10.0±11.2 | 20.8±18.5 | 25.6±24.2 |  | | | |
PYC did not significantly increase the level of total phenolics excreted in the urine (Table 4).When measuring antioxidant potential of urine, there was no measurable increase as a result of supplementation. | | |  | | Male (n=11) | Female (n=14) |  |
|---|
 | | Baseline | Pycnogenol | Baseline | Pycnogenol |  |
|---|
 | | ←mean±SD→ | ←mean±SD→ |  |
 | Phenolics, mg/mg creatinine | 0.55±0.13 | 0.54±0.17 | 0.63±0.26 | 0.73±0.22 |  |
 | FRAP,a μmol/mg creatinine | 0.51±0.13 | 0.51±0.27 | 0.67±0.22 | 0.75±0.26 |  |
 | ORAC,a μmol/mg creatinine | 3.95±1.29 | 3.08±0.90 | 4.94±2.02 | 4.64±1.42 |  | | | |
Male subjects had significantly greater fasting serum antioxidant capacity than female subjects at baseline and after the intervention (Student t test, P<.05). Because of the gender difference in fasting serum ORAC values, associations between dietary factors and fasting ORAC values were analyzed by gender. To assess total nutrient antioxidant intake for each subject, the average vitamin C, vitamin E, and selenium intake for each subject was expressed as the percentage of the dietary reference intake (DRI) for the subject's age and gender ((9)). An average percent of the DRI for all nutrient antioxidants was then determined. In female subjects, there were weak associations between the fasting ORAC concentration and the percent DRI for vitamin C (r=.30, P=.11), percent DRI for selenium (r=.27, P=.15), and average percent DRI for all nutrient antioxidants (r=.35, P=.06), but not for vitamin E (r=−.04, P=.91). Surprisingly, in male subjects, there were weak negative associations between the fasting ORAC values and the percent DRI for vitamin C (r=−.49, P=.16) and the average percent DRI for all nutrient antioxidants (r=−.39, P=.06), and no associations for selenium (r=−.23, P=.28) and vitamin E (r=−.03, P=.87). Interestingly, there was a significant negative association between fasting ORAC values and alcohol among men (r=−.44, P=.03) but not among women (r=.105, P=.58).
Discussion  PYC is used throughout Europe as a dietary supplement and is readily available to Americans on the internet ((10)). The claims surrounding the beneficial aspects of PYC are numerous. There is a large body of literature on this supplement; however, the majority of studies published to date are in vitro or cell culture studies. These studies suggest that PYC may enhance immune cell function [11], [12], act to control the inflammation response ((13)), and help protect endothelial cells against injury [14], [15], [16], [17], [18]. Among the few human studies, Virgili and colleagues ((19)) investigated the urinary excretion of a minor constituent of PYC, ferulic acid, after giving subjects doses of 100 to 400 mg. They found that subjects excreted significant but highly variable amounts of ferulic acid, providing evidence that at least part of the phenolic compounds in PYC are absorbed and excreted. Petrassi and colleagues ((20)) reported that PYC, at a dose of 300 mg/day for 2 months, significantly reduced ambulatory venous pressure and patients' perception of leg heaviness and subcutaneous edema in patients with chronic venous insufficiency. Two studies [21], [22] reported that PYC reduces platelet aggregation, but not blood pressure, in smokers 2 hours after receiving doses of 100 to 200 mg. Saliou and colleagues ((23)) found that PYC consumed at a dose of 1.10 mg/kg body weight for 4 weeks followed by a dose of 1.66 mg/kg for an additional 4 weeks reduced skin cell damage in a group of fair-skinned subjects. In a small study with 40 subjects, Spadea and Balestrazzi ((24)) reported that PYC, at a dose of 150 mg/day for 2 months, maintained retinal function and improved visual acuity in patients with diabetes atherosclerosis or other vascular diseases. The present study explored whether PYC interacts with vitamin C to increase its concentration in the body. Previously, Cossins and colleagues ((25)) studied the effects of various flavonoids and PYC on the ascorbate radical lifetime using electron spin resonance spectroscopy. These investigators theorized that flavonoids could recycle vitamin C from dehydroascorbic acid, the fully oxidized form of vitamin C, by donating two hydrogen atoms and reforming ascorbic acid. Their results showed that PYC was the most powerful compound, prolonging the ascorbate radical lifetime by 200%. Although this research showed a potential interaction between PYC and vitamin C in vitro, the present study failed to detect measurable increases in the fasting levels of plasma vitamin C in a group of healthy young men and women consuming 200 mg of PYC daily for 2 weeks along with their usual diet. The present study also explored whether PYC has antioxidant potential in vivo. Several research groups have reported that PYC shows antioxidant properties in vitro. PYC seems to be effective against reactive oxygen [26], [27] and nitrogen [28], [29] species and reduces lipid peroxidation ((30)) and protein modification by malondialdehyde ((31)). Despite these findings, the present study failed to detect any measurable increases in fasting serum total antioxidant capacity 2 weeks after supplementation or in the antioxidant capacity 1 hour after consuming a daily dose with a shake, beyond the increase observed with the shake alone. This study is the first to obtain a measure of total antioxidant capacity excreted in the urine. None of the three measures used in the present study noted a significant increase in urinary antioxidant capacity after PYC supplementation. This is also the first study to note a possible gender difference in fasting serum total antioxidant capacity. There were weak associations between dietary antioxidants and serum ORAC values in females but not in males. However, there was a significant negative association with alcohol consumption among males, possibly indicating that alcohol negates any positive benefit of nutrient antioxidants on ORAC values ((32)). Only a few studies have measured the in vivo fasting antioxidant response after the short-term ingestion (5 days to 28 days) of food or beverages known to be rich in phenolic compounds. Significant increases in the fasting antioxidant response are reported for red wine [33], [34], red grape juice ((35)), or controlled diets high in fruits and vegetables ((36)). However, other studies have reported no change in the fasting antioxidant response after consumption of red wine [32], [37], grape seed extract ((38)), black tea ((39)), controlled diets high in fruits and vegetables ((40)), or a spray-dried extract made from fruits and vegetables ((40)). Although the results of studies examining the impact of the short-term ingestion of phenolic compounds on the fasting antioxidant response remain conflicting, several other studies suggest that phenolic compounds increase the antioxidant capacity of serum or plasma after acute ingestion. The total antioxidant capacity of serum increased and peaked within 30 minutes to 2 hours after ingestion of red wine or whiskey [41], [42], [43], [44], grape seed extract ((38)), red grape juice ((35)), green or black tea [44], [45], semisweet chocolate ((46)), and cranberry juice ((47)). In the present study (and unlike those previously conducted), the acute dose of PYC was administered with a beverage to mimic the consumption of the dietary supplement with a meal. The total serum antioxidant capacity increased only 3% more than the apparent meal-induced increase in total antioxidant capacity 1 hour after ingestion. This meal-induced increase in serum antioxidant capacity has been previously reported [48], [49]. It is not known why this phenomenon occurs, but it may be the result of an increased internal release of antioxidants into the blood caused by oxygen consumption and energy expenditure increases after a meal ((49)). This study had some limitations. First, our subjects were healthy young adults. We cannot rule out the possibility that this supplement may be of benefit to older adults or individuals with altered antioxidant status because of smoking or disease. Second, there is no single measure that provides a complete picture of antioxidant status, although plasma ORAC measures have proven successful in assessing changes in the order of 10% to 15% in two studies [36], [48]. The ORAC assay, as used in this study, measures changes in the aqueous compartments of the cell and thus may not reflect changes in lipophilic antioxidants. To get a complete picture of antioxidant status, a battery of assays is needed. In a recent compilation by Pryor ((50)), many of these assays are discussed. Third, this study collected only one sample of blood after the ingestion of the daily dose. It may be that ORAC values after the load dose of PYC continue to increase beyond 1 hour after ingestion. Fourth, our sample size was small and dietary intake was not under our direct control. The antioxidant results of this study are not surprising after comparing the antioxidant potential (ORAC assay) of the daily dose of PYC with common servings of fresh fruits and vegetables. The daily dose of PYC provides only 600 ORAC units (1 unit=1 μM TE), whereas 6 prunes provides 2,885, 2/3 cup of blueberries provides 2,400, and cup of spinach provides 1,260 ((51)). The total observed urinary output of approximately 6,000 units per day suggests that normal intake is in that range. Previously, intake from fruits and vegetables (2-3 servings) has been estimated to be 1,640 units ((36)), and by increasing the servings of fruits and vegetables to 10 per day, ORAC intake was approximately 3,700 units per day. Thus the increase of about 600 units from the PYC in this study is a relatively low fraction of the total potential intake. Increases in ORAC intakes of 3,000 units have produced increases in in vivo antioxidant capacity as indicated by ORAC and FRAP measures [36], [48]. In conclusion, PYC, at a dose of 200 mg per day, does not appear to enhance the in vivo concentration of vitamin C or act as a potent antioxidant in healthy young adults.
Applications  ■Most claims made by the distributors of dietary supplements have not been substantiated by well-controlled human research studies. Dietetic professionals can disseminate to clients and consumers accurate and scientifically verifiable information concerning the validity of claims for dietary supplements. Our study found nothing to support distributors' claims. We suggest that consumers eat fruits and vegetables rich in nutrient and nonnutrient antioxidants ((52)) to improve their vitamin C and antioxidant status, rather than a dietary supplement with questionable health claims. References  References[1].
[1]
Rice-Evans CA, Packer L.
FLAVONOIDS IN HEALTH AND DISEASE.
New York, NY: Marcel Dekker; 1998;. [2].
[2]
Packer L, Rimbach G, Virgili F.
Antioxidant activity and biological properties of a procyanidin-rich extract from the pine (PINUS MARITIMA) bark. Pycnogenol.
FREE RADICAL BIOL MED. 1999;27:704–724. [3].
[3]
Bravo L.
Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance.
NUTR REV. 1998;56:317–333. MEDLINE [4].
[4]
King A, Young G.
Characteristics and occurrence of phenolic phytochemicals.
J AM DIET ASSOC. 1999;99:213–218. Abstract | Full Text |
Full-Text PDF (451 KB)
|
CrossRef
[5].
[5]
Zapata S, Dufour J.
Ascorbic, dehydroascorbic and isoascorbic acid simultaneous determinations by reverse phase ion interaction HPLC.
J FOOD SCI. 1992;57:506–511. [6].
[6]
Cao G, Verdon CP, Wu AHB, Wang H, Prior RL.
Automated oxygen radical absorbance capacity assay using the COBAS FARA II.
CLIN CHEM. 1995;41:1738–1744. MEDLINE [7].
[7]
Slinkard K, Singleton VL.
Total phenol analysis: automation and comparison with manual methods.
AM J ENOL VITICULTURE. 1977;28:49–55. [8].
[8]
Benzie IFF, Strain JJ.
The ferric reducing ability of plasma (FRAP) as a measure of ″antioxidant power”: the FRAP assay.
ANAL BIOCHEM. 1996;239:70–76. MEDLINE |
CrossRef
[9].
[9]
Institute of Medicine. Panel on Dietary Antioxidants and Related Compounds .
DIETARY REFERENCE INTAKES: VITAMIN C, VITAMIN E, SELENIUM, AND CAROTENOIDS.
Washington, DC: National Academy Press; 2000;. [10].
[10]
Berkeley UC.
Wellness Letter, Wellness Guide to Dietary Supplements.
http://www.berkeleywellness.com/html/ds/dsPycnogenol.html
February 2002.;
. [11].
[11]
Cheshier JE, Ardestani-Kaboudanian S, Liang B, Araghiniknam M, Chung S, Lane L, et al.
Immunomodulation by Pycnogenol in retrovirus-infected or ethanol-fed mice.
LIFE SCI. 1996;58:87–96. [12].
[12]
Liu FJ, Zhang XY, Lau BH.
Pycnogenol enhances immune and haempoietic functions in senescence-accelerated mice.
CELL MOL LIFE SCI. 1998;54:1168–1172.
CrossRef
[13].
[13]
Cho KJ, Yun CH, Yoon DY, Cho YS, Rimbach G, Packer L, et al.
Effect of bioflavonoids extracted from the bark of PINUS MARITIMA on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7.
TOXICOL APPL PHARMACOL. 2000;68:64–71. [14].
[14]
Rong Y, Li L, Shah V, Lau BH.
Pycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induce oxidant injury.
BIOTECHNOL THER. 1994 95;5:117–126. MEDLINE [15].
[15]
Fitzpartrick DF, Bing B, Rohdewald P.
Endothelium-dependent vascular effects of Pycnogenol.
J CARDIOVASC PHARMACOL. 1998;32:509–515. MEDLINE |
CrossRef
[16].
[16]
Virgili F, Kim D, Packer L.
Procyanidins extracted from pine bark protect alpha-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages: role of nitric oxide and peroxynitrite.
FEBS LETT. 1998;431:315–318. Abstract | Full Text |
Full-Text PDF (172 KB)
|
CrossRef
[17].
[17]
Liu F, Lau BH, Peng Q, Shad V.
Pycnogenol protects vascular endothelial cells from beta-amyloid-induced injury.
BIOL PHARM BULL. 2000;23:735–737. MEDLINE [18].
[18]
Peng Q, Wei Z, Lau BH.
Pycnogenol inhibits tumor necrosis factor-alpha-induced nuclear factor kappa B activation and adhesion molecule expression in human vascular endothelial cells.
CELL MOL LIFE SCI. 2000;57:834–841.
CrossRef
[19].
[19]
Virgili F, Pagana G, Bourne L, Rimbach G, Natella F, Rice-Evans C, et al.
Ferulic acid excretion as a marker of consumption of a French maritime pine (PINUS MARITIMA) bark extract.
FREE RADICAL BIOL MED. 2000;28:1249–1256. [20].
[20]
Petrassi C, Mastromarino A, Spartera C.
Pycnogenol in chronic venous insufficiency.
PHYTOMED. 2000;7:383–388. [21].
[21]
Araghi-Niknam M, Hosseini S, Larson D, Rohdewald P, Ross Watson R.
Pine bark extract reduces platelet aggregation.
INT MED. 1999;2:73–77. [22].
[22]
Putter M, Grotemeyer KH, Wurthwein G, Araghi,Niknam M, Watson RR, Hosseini S, et al.
Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol.
THROMB RES. 1999;95:155–161. Abstract | Full Text |
Full-Text PDF (182 KB)
|
CrossRef
[23].
[23]
Saliou C, Rimbach G, Moini H, McLaughlin L, Hosseini S, Lee J, et al.
Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract.
FREE RADIC BIOL MED. 2001;15:154–160. [24].
[24]
Spadea L, Balestrazzi E.
Treatment of vascular retinopathies with Pycnogenol.
PHYTOTHER RES. 2001;15:219–223.
CrossRef
[25].
[25]
Cossins E, Reaching L, Packer L.
ESR studies of vitamin C regeneration, order of reactivity of natural source phytochemical preparations.
BIOCHEM MOL BIOL INT. 1998;45:583–597. MEDLINE [26].
[26]
Macrides TA, Shihata A, Kalafatis N, Wright PF.
A comparison of the hydroxyl radical scavenging properties of the shark bile steroid 5 beta-scymnol and plant Pycnogenols.
BIOCHEM MOL BIOL INT. 1997;42:1249–1260. MEDLINE [27].
[27]
Noda Y, Anzai K, Mori A, Kohno M, Shinmei M, Packer L.
Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectrometer system.
BIOCHEM MOL BIOL INT. 1997;42:35–44. MEDLINE [28].
[28]
Virgili F, Kobuchi H, Packer L.
Procyanidins extracted from PINUS MARITIMA (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages.
FREE RADIC BIOL MED. 1998;24:1120–1129. MEDLINE |
CrossRef
[29].
[29]
Park YC, Rimbach G, Saliou C, Valacchi G, Packer L.
Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages.
FEBS LETT. 2000;14:97–98. [30].
[30]
Udea T, Udea T, Armstrong D.
Preventative effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye.
OPHTHALMIC RES. 1996;28:184–192. MEDLINE |
CrossRef
[31].
[31]
Kim J, Chehade J, Pinnas JL, Mooradian AD.
Effect of select antioxidants on malondialdehyde modification of proteins.
NUTRITION. 2000;16:1079–1081. Abstract | Full Text |
Full-Text PDF (55 KB)
|
CrossRef
[32].
[32]
van der Gaag MS, van den Berg R, van den Berg H, Schaafsma G, Hendriks HF.
Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men.
EUR J CLIN NUTR. 2000;54:586–591. MEDLINE |
CrossRef
[33].
[33]
Fuhrman B, Lavy A, Aviram M.
Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation.
AM J CLIN NUTR. 1995;61:549–554. MEDLINE [34].
[34]
Nigkikar SV, Williams NR, Griffin BA, Howard AN.
Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo.
AM J CLIN NUTR. 1998;68:258–265. MEDLINE [35].
[35]
Day AP, Kemp HJ, Bolton C, Hartog M, Stansbie D.
Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation.
ANN NUTR METAB. 1997;41:353–357. MEDLINE |
CrossRef
[36].
[36]
Cao G, Booth SL, Sadowski JA, Prior RL.
Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables.
AM J CLIN NUTR. 1998;68:1081–1087. MEDLINE [37].
[37]
de Rijke , Demacker PN, Assen NA, Sloots LM, Katan MB, Stalenhoef AF.
Red wine does not affect oxidizability of low-density lipoproteins in volunteers.
AM J CLIN NUTR. 1996;63:329–334. MEDLINE [38].
[38]
Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P.
An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect.
J CLIN PHARM THER. 1998;23:385–389. MEDLINE |
CrossRef
[39].
[39]
McAnlis GT, McEneny J, Pearce J, Young IS.
Black tea consumption does not protect low density lipoprotein from oxidative modification.
EUR J CLIN NUTR. 1998;52:202–206. MEDLINE [40].
[40]
Record IR, Dreosti IE, McInerney JK.
Changes in plasma antioxidant status following consumption of diets high or low in fruits and vegetables or following dietary supplementation with an antioxidant mixture.
BR J NUTR. 2001;85:459–464. MEDLINE |
CrossRef
[41].
[41]
Whitehead TP, Robinson D, Allaway S, Syms J, Hale A.
Effect of red wine ingestion on the antioxidant capacity of serum.
CLIN CHEM. 1995;41:32–35. MEDLINE [42].
[42]
Duthie GG, Pedersen MW, Gardner PT, Morrice PC, Jenkinson AM, McPhail DB, et al.
The effect of whiskey and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers.
EUR J CLIN NUTR. 1998;52:733–736. MEDLINE [43].
[43]
Serafini M, Giuseppe M, Ferro-Luzzi A.
Alcohol-free red wine enhances plasma antioxidant capacity in humans.
J NUTR. 1998;128:1003–1007. MEDLINE [44].
[44]
Serafini M, Laranjinha JA, Almeida LM, Maiani G.
Inhibition of human LDL lipid peroxidation by phenol-rich beverages and their impact on total antioxidant capacity in humans.
J NUTR BIOCHEM. 2000;11:585–590. Abstract | Full Text |
Full-Text PDF (172 KB)
|
CrossRef
[45].
[45]
Serafini M, Ghiselli A, Ferro-Luzzi A.
In vivo antioxidant effect of green and black tea in man.
EUR J CLIN NUTR. 1996;50:28–32. MEDLINE [46].
[46]
Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, Fraga CG.
Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status.
J NUTR. 2000;130:2109S–2114S. MEDLINE [47].
[47]
Pedersen CB, Jenkinson KJ, Gardner PT, McPhail DB, Duthie GG.
Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy volunteers.
EUR J CLIN NUTR. 2000;54:405–408. MEDLINE |
CrossRef
[48].
[48]
Cao G, Russell RM, Lischner N, Prior RL.
Serum antioxidant capacity is increased by consumption of strawberries, spinach, red wine or vitamin C in elderly women.
J NUTR. 1998;128:2383–2390. MEDLINE [49].
[49]
Cao G, Prior RL.
Postprandial increases in serum antioxidant capacity in older women.
J APPL PHYSIOL. 2000;89:877–883. [50].
[50]
Pryor WA.
BIO-ASSAYS FOR OXIDATIVE STRESS STATUS.
New York, NY: Elsevier; 2001;. [51].
[51]
United States Department of Agricultural Research Service .
Food and Nutrition Research Briefs.
http://www.ars.usda.gov/is/np/fnrb/fnrb499.htm#Antioxidant
February 2002.;
. [52].
[52]
Craig WJ.
Phytochemicals: guardians of our health.
J AM DIET ASSOC. 1997;97:S199–204
. Abstract | Full Text |
Full-Text PDF (662 KB)
|
CrossRef
K. Silliman is a professor and J. Parry is with the Department of Biological Sciences (Program in Nutrition and Food Science), and L. L. Kirk is a professor, Department of Chemistry, California State University, Chico. R. L. Prior is a research chemist, USDA, ARS, Arkansas Children's Nutrition Center, Little-Rock PII: S0002-8223(02)00008-1 doi:10.1053/jada.2003.5004 © 2003 American Dietetic Association. Published by Elsevier Inc. All rights reserved. | |
|